Joint venture aims to develop up to 10 new cell and gene therapy products targeting areas with high unmet medical needs.
AstraZeneca Finalizes Equity Investment, Research Collaboration with Cellectis
Posted on by admin
![](https://onclive.s3.amazonaws.com/onclive_630x1200.png)
1 min read
+ There are no comments
Add yours